Related Experiment Video

Updated: Jun 17, 2026

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes

Juan R Cubillos-Ruiz1, Melanie Rutkowski, Jose R Conejo-Garcia

  • 1Departments of Microbiology and Immunology, Lebanon, NH, USA.

Cell Cycle (Georgetown, Tex.)
|December 22, 2009
PubMed

Insights

Targeting tumor-infiltrating leukocytes, like regulatory T cells, offers a novel strategy to improve survival rates for metastatic ovarian cancer patients. Modulating these cells complements chemotherapy and surgery for better outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Current metastatic ovarian carcinoma treatments (debulking surgery + chemotherapy) yield poor 5-year survival rates (<30%).
  • Tumor-infiltrating leukocytes, including regulatory T cells and myeloid cells, are critical drivers of ovarian cancer progression.
  • Novel therapeutic strategies are essential to overcome treatment resistance and improve patient outcomes.

Purpose of the Study:

  • To review the potential of eliminating or modulating leukocytes within the ovarian cancer microenvironment.
  • To explore novel interventions that complement standard ovarian cancer therapies.
  • To discuss the impact of targeting these immune cells on tumor progression and anti-tumor immunity.

Main Methods:

  • Literature review focusing on recent advancements in understanding leukocyte roles in ovarian cancer.
  • Analysis of in vivo and in situ strategies for leukocyte modulation.
  • Discussion of the effects of targeting microenvironmental leukocytes on cancer hallmarks.

Main Results:

  • Leukocytes significantly influence ovarian cancer vascularization, local growth, and metastatic spread.
  • Modulating these immune cells can potentially enhance spontaneous anti-tumor immune responses.
  • Targeting leukocytes represents a promising complementary approach to existing treatments.

Conclusions:

  • Eliminating or modulating tumor-associated leukocytes is a viable novel strategy for metastatic ovarian cancer.
  • This approach can impact tumor vascularization, growth, metastasis, and immune surveillance.
  • Targeting the tumor microenvironment's immune cells offers a promising avenue to improve therapeutic efficacy.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...